Advancing excellence in laboratory medicine for better healthcare worldwide

Doctor Andrea FERREIRA-GONZALEZ selected to receive the 2020 IFCC Award for Significant Contributions in Molecular Diagnostics

Milan, 24 April 2020 - The IFCC, the international leading organization in the field of Clinical Chemistry and Laboratory Medicine, is pleased to announce that Dr Andrea FERREIRA-GONZALEZ (Molecular Diagnostics Division, Virginia Commonwealth University, Richmond, VA - USA), has been selected to receive the IFCC Award for Significant Contributions in Molecular Diagnostics, sponsored by Abbott Molecular. This award honours an individual who has made unique contributions to the promotion and understanding of molecular biology and its application in Clinical Chemistry and Laboratory Medicine worldwide. The IFCC is very pleased to acknowledge the support from Abbott Molecular in the recognition of scientists and educators with a distinguished career in this area.

Dr Ferreira-Gonzalez has devoted over 25 years to the development of the field of Molecular Diagnostics for which she has been recognized nationally and internationally. She helped shaping clinical molecular diagnostics practices through her involvement in guideline development with the Clinical and Laboratory Standards Institute (MM-6A1 and MM9A1) and involvement with AACC’s task force on advisability of creating a certifying examination in clinical molecular diagnostics. She has actively participated in several national and international associations that play key roles in improving clinical laboratory practice, education, and translational research. Dr Ferreira-Gonzalez is a founding member of the molecular diagnostics field. She has contributed significantly to the technical, clinical, and regulatory aspects of molecular diagnostics and she continues to be a voice for laboratories around the world engaged in this testing.

Prof. Maurizio FERRARI, IFCC President and Chair IFCC Awards Committee, said: "We are delighted in selecting Dr Andrea FERREIRA-GONZALEZ for the 2020 IFCC Award for Significant Contributions in Molecular Diagnostics. She has a remarkable career in the field of clinical chemistry and laboratory medicine and has made ongoing contributions to the profession by providing specialist and authoritative advisory services on aspects of scientific research and development in molecular monitoring. I really believe that Dr Ferreira-Gonzalez is a most worthy recipient of the 2020 IFCC Award for Significant Contributions in Molecular Diagnostics”.

The 2020 IFCC Awardees are a witness of the contribution that IFCC gives to advancement of excellence in laboratory medicine for better healthcare worldwide. Doctor Ferreira-Gonzalez along with nine other IFCC Distinguished Award winners will be formally announced on Wednesday 6th January 2021 at the Opening Ceremony of the 24th WorldLab - IFCC International Congress in Clinical Chemistry and Laboratory Medicine to be held in Seoul (South Korea) from 6th to 10th January 2021.

- end -

Click here to download the press release

ABOUT IFCC

IFCC is the leading organization in the field of Clinical Chemistry and Laboratory Medicine worldwide. Through leadership and innovation in science and education, IFCC strives to enhance the scientific level and the quality of diagnosis and therapy for patients throughout the world. IFCC builds on the professionalism of its members to provide quality services to patients. IFCC is a Federation of 93 Full Member and 17 Affiliate member Societies of Clinical Chemistry and Laboratory Medicine representing more than 45.000 individual clinical chemists, laboratory scientists, and laboratory physicians and 48 Corporate Members covering the major areas of clinical laboratory developments. For further details please contact: ifcc@ifcc.org.

 


ABOUT
Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacturing and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 99,000 people and markets its products in more than 150 countries. Abbott Diagnostics is a global leader in in vitro diagnostics and offers a broad range of innovative instrument systems and tests for hospitals, reference labs, molecular labs, blood banks, physician offices and clinics. Abbott's diagnostic solutions offer customers automation, convenience, bedside testing, cost effectiveness and flexibility. Website: www.abbott.com

 
Website developed by Insoft